Related Experiment Video
Updated: May 30, 2026

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
Congenital cytomegalovirus infection: an overview
1Department of Pediatrics, University of Arizona Health Sciences Center, Tucson, AZ 85724-5073, USA. elliotts@email.arizona.edu
Abstract:
Cytomegalovirus (CMV) remains the most common cause of congenitally-acquired infection in the United States and is a leading infectious cause of sensorineural hearing loss, cognitive delay, and permanent neurologic sequelae. Although most cases of congenital CMV infection are asymptomatic, significant morbidity and mortality exist for symptomatic infants and may also occur in asymptomatic ones. Diagnosis remains relatively straightforward, but treatment options are limited and associated with some toxicity. Efforts at prevention via vaccination, screening, and improved epidemiology deserve high priority to limit the impact of this common infection.
Insights
Cytomegalovirus (CMV) is a common congenital infection in the US, potentially causing hearing loss and neurologic issues. Prevention strategies like vaccination and screening are crucial due to limited treatment options.
Area of Science:
- Virology
- Pediatrics
- Public Health
Background:
- Cytomegalovirus (CMV) is the most frequent congenital infection in the US.
- It is a primary cause of sensorineural hearing loss, cognitive delays, and neurological deficits in infants.
- While many congenital CMV infections are asymptomatic, severe outcomes can occur in both symptomatic and asymptomatic infants.
Purpose of the Study:
- To highlight the significant impact of congenital Cytomegalovirus (CMV) infection.
- To underscore the challenges in managing CMV, including limited treatment options and associated toxicities.
- To emphasize the urgent need for enhanced prevention strategies.
Main Methods:
- Review of current epidemiological data on congenital CMV infection.
- Analysis of diagnostic approaches for CMV.
- Evaluation of existing and potential therapeutic interventions for CMV.
- Assessment of prevention strategies including vaccination, screening, and public health initiatives.
Main Results:
- Congenital CMV infection is highly prevalent and a leading cause of infant neurodevelopmental disabilities.
- Diagnosis is feasible, but effective and safe treatment options remain limited.
- Prevention through vaccination, screening, and epidemiological studies is critical.
Conclusions:
- Cytomegalovirus (CMV) poses a substantial public health challenge due to its prevalence and potential for severe sequelae.
- Effective prevention strategies are paramount given the limitations in current treatment options.
- Continued research and implementation of public health measures are essential to mitigate the impact of congenital CMV.
More Related Videos
05:51Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
08:08qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue
Published on: July 9, 2014
Related Concept Videos
Cytomegalovirus Disease
Cryptococcal Meningitis
Respiratory Syncytial Virus Disease
Viral Hepatitis I: Introduction
Bacterial Meningitis I: Introduction
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...